Technologies that destroy tissue for therapeutic benefit are collectively known as ablation technologies. By a wide range of energy types or other mechanical methods, they are used to destroy, excise or otherwise treat tissue for therapeutic benefit, from the radiation of cancer, the destruction of the endometrial lining of the uterus causing endometriosis, the creation [...]
The applications of energy-based technologies for the ablative treatment of tissue are numerous and diverse as a result of the effectiveness of these technologies — which vary widely by energy type (electrosurgery, radiosurgery, gamma knife, brachytherapy, cryogenic therapy, fluidjet/hydrotherapy, microwave ablation, radiofrequency ablation, laser, thermal ablation, and ultrasonic ablation) — and their integration into routine [...]
PRLog (Press Release) – Jun 09, 2010 – The practice of surgery has long employed energy-based technologies to excise, cut, ablate, cauterize, destroy or otherwise manipulate tissue to produce therapeutic results. Various energy modalities — from cryotherapy to microwave to radiofrequency to ultrasound to radiation and others — have proven their ability to effect healthy or diseased tissue [...]
The evolution of treatments for coronary artery disease has historically been dynamic and, with the stakes still high for effective treatment and many different technologies in active development by medtech manufactures, that evolution will be continuing shift over the coming years. Setting aside, for the moment, the trends in coronary artery bypass graft surgery, encompassing [...]
Angioplasty and the use of drug-eluting stents are being compared to coronary artery bypass graft surgery in a study reported in the April 15 issue of the American Journal of Cardiology. Due to the invasiveness of bypass surgery, which most often involves the use of a sternotomy and cardiopulmonary bypass (CPB), both of which are [...]
With the FDA's approval of Medtronic's Melody Transcatheter Pulmonary Valve and Ensemble Delivery System (see link), another step has been made toward eliminating traditional surgery — at least that's the idea. The ability to implant a valve via a percutaneous procedure advances the art of less invasive intervention in ways akin to laparoscopic surgery, albeit at [...]
Until the advent of coronary stents, patients with cardiovascular blockages had little choice but to either keep a close eye on their disease (“watchful waiting” with or without accompanying pharmaceutical therapy) or undergo coronary artery bypass grafting (CABG). When angioplasty was developed by Andreas Gruentzig in 1977, patients were presented with the option to undergo [...]
Because of the invasive nature of cardiac surgery, medical therapy will always be the preferred treatment protocol favored by many clinicians. To that end, researchers and pharmaceutical manufacturers continue to explore methods of treating atherosclerosis that will render surgery unnecessary. For instance, researchers at the Medical University of Graz in Austria announced in February 2009 [...]
Below are select technologies under development at recently identified medtechs startups: Scaffold for regeneration of functional bone tissues. Autologous, adipose-derived stem cells for treatment of traumatic brain injury and chronic obstructive pulmonary disease. Device company developing technologies to improve the safety and efficiency of chemotherapy. Developing stem cell therapies. Devices to locate and protect nerves [...]
High-strength surgical glue products were approved for topical closure applications in the United States in the late 1990s. Outside the United States, high-strength glues and adhesives have been approved in some countries for a number of years and have built up a track record of use in internal surgery. With time, high-strength glues will come [...]
Contact:
